Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
- PMID: 8308015
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
Abstract
We have used a transient transfection system with a cytomegalovirus-based vector expressing high levels of biologically active human estrogen receptor (ER) in COS-1 cells to study the phosphorylation of human ER and to identify major hormone-regulated phosphorylation sites. The features of phosphorylation of the wild-type ER were very similar to those previously observed for the endogenous ER in uterine cells: The ER exhibited a basal level of phosphorylation which was increased approximately 3-4-fold by estrogen (estradiol) and by antiestrogens (hydroxytamoxifen and ICI164,384), and phosphorylation was increased to an almost similar extent by activation of either protein kinase A or C signal transduction pathways with cholera toxin plus isobutyl methylxanthine (CT+IBMX) or phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively. Phosphoamino acid analysis revealed that the phosphorylation occurred exclusively on serine residues in all cases. Tryptic phosphopeptide analysis of ER, using a two-dimensional peptide mapping procedure, revealed similar patterns for ER in cells treated with estradiol, antiestrogens or TPA; with CT+IBMX treatment, the same phosphopeptides were seen, but the relative phosphorylation of the different ER phosphotryptic peptides differed. In ER deleted of the NH2-terminal A and B (A/B) domains, estrogen and antiestrogen-stimulated phosphorylations were abolished, while the phosphorylation induced by CT+IBMX was maintained. This suggests that sites of phosphorylation enhanced by estradiol and antiestrogen, but not those induced by CT+IBMX, are located in the A/B domain. These results were further confirmed by comparing the tryptic phosphopeptide patterns of wild-type and A/B-deleted receptor upon estradiol and CT+IBMX treatments, and then by site-directed mutagenesis, by substituting alanines for the serine residues in the A/B domain (Ser104, Ser106, Ser118, Ser154, and Ser167) involved in known protein kinase consensus sequences. Comparison of the tryptic phosphopeptide patterns of wild-type ER and these mutant ERs allowed us to identify serine 104 and/or serine 106 and serine 118, all three being part of a serine-proline motif, the preferred substrate of proline-directed protein kinase, as major ER phosphorylation sites. When tested with two estrogen-responsive reporter gene constructs in several cell types, the mutant S104A, S106A, S118A showed a approximately 40% reduction in transactivation activity in response to E2, while the mutants S118A and S104A, S106A alone showed a approximately 15% decrease in transactivation. Our studies identify several serines in the NH2-terminal portion of the human ER as being major hormone-regulated phosphorylation sites.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. doi: 10.1016/s0960-0760(00)00104-7. J Steroid Biochem Mol Biol. 2000. PMID: 11162936 Review.
-
William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.Breast Cancer Res Treat. 1993;27(1-2):17-26. doi: 10.1007/BF00683190. Breast Cancer Res Treat. 1993. PMID: 8260727 Review.
-
Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.Mol Endocrinol. 1993 Mar;7(3):441-52. doi: 10.1210/mend.7.3.7683375. Mol Endocrinol. 1993. PMID: 7683375
-
Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.Mol Endocrinol. 1994 Oct;8(10):1397-406. doi: 10.1210/mend.8.10.7531820. Mol Endocrinol. 1994. PMID: 7531820
-
The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.Mol Endocrinol. 1995 Jul;9(7):814-25. doi: 10.1210/mend.9.7.7476965. Mol Endocrinol. 1995. PMID: 7476965
Cited by
-
Deciphering the Role of BCAR3 in Cancer Progression: Gene Regulation, Signal Transduction, and Therapeutic Implications.Cancers (Basel). 2024 Apr 26;16(9):1674. doi: 10.3390/cancers16091674. Cancers (Basel). 2024. PMID: 38730626 Free PMC article. Review.
-
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.Front Endocrinol (Lausanne). 2023 Aug 30;14:1250218. doi: 10.3389/fendo.2023.1250218. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37711895 Free PMC article. Review.
-
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells.Sci Adv. 2023 May 12;9(19):eadd3685. doi: 10.1126/sciadv.add3685. Epub 2023 May 12. Sci Adv. 2023. PMID: 37172090 Free PMC article.
-
Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.Front Endocrinol (Lausanne). 2022 Nov 28;13:1075830. doi: 10.3389/fendo.2022.1075830. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36518248 Free PMC article.
-
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic.Explor Target Antitumor Ther. 2022;3(2):172-199. doi: 10.37349/etat.2022.00078. Epub 2022 Apr 24. Explor Target Antitumor Ther. 2022. PMID: 36046843 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases